题名 | Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial | 链接 | https://www.sciencedirect.com/science/article/abs/pii/S2213858719301925 |
求助Supplementary Material部分内容 |